Liabilities / Assets
50th percentile
Higher debt load relative to assets than 50% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
50th percentile
Higher debt load relative to assets than 50% of similar nonprofits.
Liabilities / Revenue
70th percentile
Higher debt load relative to revenue than 70% of similar nonprofits.
Net Margin
97th percentile
Higher net margin than 97% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
85th percentile
Faster asset growth than 85% of similar nonprofits.
Revenue Growth
63rd percentile
Faster revenue growth than 63% of similar nonprofits.
Assets
Up$4,618,668
Up $834,672 (+22%) from 2011
Net Assets
Up$4,022,512
Up $884,162 (+28%) from 2011
Liabilities
Down$596,156
Down $49,490 (-7.7%) from 2011
Revenue
$1,716,740
No earlier filing loaded for comparison.
Expenses
Down$357,000
Down $279,751 (-44%) from 2011
Net Income
$1,359,740
No earlier filing loaded for comparison.
This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Charley's fund's singular mission is to support the development of treatments and a cure for duchenne muscular dystrophy (dmd). We identify and direct funding to the most compelling research and treatment programs related to dmd and, (cont. On sch. O.)
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2012 • Form 990Summary only. Only limited summary data is available for this year.